Evaluating Treatments for Amyotrophic Lateral Sclerosis

The HEALEY ALS platform is an innovative first attempt at platform trials in ALS, looking to slow ALS disease progression. Author Sabrina Paganoni, MD, PhD, of Massachusetts General Hospital and Harvard Medical School, discusses results of the first 4 drug regimens from this platform trial and how this study design makes efficient use of resources, with JAMA Deputy Editor Christopher Muth, MD. Related Content: Platform Clinical Trials for the Efficient Evaluation of Multiple Treatments Pridopidine in Amyotrophic Lateral Sclerosis Platform Trials in ALS Verdiperstat in Amyotrophic Lateral Sclerosis Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis CNM-Au8 in Amyotrophic Lateral Sclerosis

You can listen to Evaluating Treatments for Amyotrophic Lateral Sclerosis online on Radio and Podcast. Open the player on this page to stream the available audio.

Evaluating Treatments for Amyotrophic Lateral Sclerosis is an episode from JAMA Author Interviews: Covering research in medicine, science, & clinical practice. For physicians, researchers, & clinicians. by American Medical Association.

This episode is 22:34 long.

This episode was published on Feb 17, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from JAMA Author Interviews: Covering research in medicine, science, & clinical practice. For physicians, researchers, & clinicians. when more episodes are available from the podcast feed.